QVT Financial’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-500,449
Closed -$4.32M 73
2016
Q2
$4.32M Sell
500,449
-193,987
-28% -$1.91M 0.3% 59
2016
Q1
$6.58M Buy
694,436
+208,160
+43% +$1.96M 0.4% 59
2015
Q4
$8.43M Hold
486,276
0.47% 51
2015
Q3
$6.53M Sell
486,276
-186,607
-28% -$3.75M 0.22% 61
2015
Q2
$15.2M Sell
672,883
-178,422
-21% -$3.14M 0.23% 44
2015
Q1
$12.2M Sell
851,305
-1,158,881
-58% -$16.7M 0.68% 41
2014
Q4
$19.4M Sell
2,010,186
-2,045,404
-50% -$18.2M 0.97% 28
2014
Q3
$36.9M Sell
4,055,590
-500,500
-11% -$4.77M 1.9% 17
2014
Q2
$45M Buy
4,556,090
+337,290
+8% +$2.86M 2.43% 12
2014
Q1
$53.6M Hold
4,218,800
3.07% 8
2013
Q4
$63.2M Sell
4,218,800
-301,000
-7% -$3.87M 3.71% 5
2013
Q3
$49.9M Sell
4,519,800
-81,700
-2% -$681K 3.4% 6
2013
Q2
$36.6M Buy
+4,601,500
New +$29.3M 2.46% 13

Other funds holding HALO

QVT Financial's HALO Position: Q3 2016 in Review

QVT Financial sold out of Halozyme (HALO) in Q3 2016, closing a stake of 500,449 shares — an estimated $4.32M sold.

QVT Financial first reported a position in HALO in Q2 2013 and held it in 13 quarters. The position peaked at $63.2M in Q4 2013. 162 funds tracked by Wall St. Rank hold HALO as of Q3 2016.

  • QVT Financial reported no remaining Halozyme position as of Q3 2016 after selling out during the quarter.
  • QVT Financial sold 500,449 Halozyme shares in Q3 2016, an estimated $4.32M.
  • QVT Financial first reported a position in Halozyme in Q2 2013 and held it in 13 quarters.
  • QVT Financial's Halozyme position peaked at $63.2M in Q4 2013.
  • 162 funds tracked by Wall St. Rank held Halozyme as of Q3 2016.

Based on QVT Financial's 13F filing for Q3 2016, filed 14 Nov 2016.